Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-12-001801
Filing Date
2012-08-14
Accepted
2012-08-14 16:47:01
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 biostarpharma10q063012.htm 10-Q 1373055
2 ex31-1.htm EX-31.1 17849
3 ex31-2.htm EX-31.2 17556
4 ex32-1.htm EX-32.1 6449
5 ex32-2.htm EX-32.2 6292
  Complete submission text file 0001185185-12-001801.txt   5907847

Data Files

Seq Description Document Type Size
6 bspm-20120630.xml EX-101.INS 933267
7 bspm-20120630.xsd EX-101.SCH 40039
8 bspm-20120630_cal.xml EX-101.CAL 42826
9 bspm-20120630_def.xml EX-101.DEF 208903
10 bspm-20120630_lab.xml EX-101.LAB 247543
11 bspm-20120630_pre.xml EX-101.PRE 212318
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

EIN.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34708 | Film No.: 121033766
SIC: 2834 Pharmaceutical Preparations